Models matter: the search for an effective Staphylococcus aureus vaccine (Q59806683)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24998740%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Models matter: the search for an effective Staphylococcus aureus vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24998740%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

main subject

Staphylococcus aureus

1 reference

inferred from title

author

Wilmara Salgado-Pabón

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24998740%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Patrick M. Schlievert

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24998740%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Patrick M. Schlievert

series ordinal

2

0 references

language of work or name

English

0 references

publication date

7 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24998740%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Microbiology

21 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24998740%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24998740%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24998740%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

585-591

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24998740%20AND%20SRC:MED&resulttype=core&format=json

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

21 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Exotoxins of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Staphylococcus aureus infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Staphylococcal vaccines and immunotherapy: to dream the impossible dream?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Anti-Staphylococcus aureus immunotherapy: current status and prospects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Immunotherapeutic approaches against Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Challenges for a universal Staphylococcus aureus vaccine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Staphylococcus aureus: a pathogen with still unresolved issues.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Vaccination and passive immunisation against Staphylococcus aureus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Where does a Staphylococcus aureus vaccine stand?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Development of a vaccine against Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Is there a future for a Staphylococcus aureus vaccine?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Exploring Staphylococcus aureus pathways to disease for vaccine development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Progress toward a Staphylococcus aureus vaccine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Staphylococcal and streptococcal superantigen exotoxins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Superantigens are critical for Staphylococcus aureus Infective endocarditis, sepsis, and acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Genomic responses in mouse models poorly mimic human inflammatory diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

On the emerging role of rabbit as human disease model and the instrumental role of novel transgenic tools.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Cytolysins, superantigens, and pneumonia due to community-associated methicillin-resistant Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

MSCRAMM-mediated adherence of microorganisms to host tissues.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Surface protein adhesins of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Enterococcus faecalis endocarditis severity in rabbits is reduced by IgG Fabs interfering with aggregation substance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Aggregation and binding substances enhance pathogenicity in a rabbit model of Enterococcus faecalis endocarditis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Interferon in human serum after injection of endotoxin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

The susceptibility of mice to bacterial endotoxins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Toxic shock syndrome surveillance in the United States, 1980 to 1981

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Toxic shock syndrome associated with surgical wound infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Comparison of Staphylococcus aureus strains for ability to cause infective endocarditis and lethal sepsis in rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Glycerol monolaurate antibacterial activity in broth and biofilm cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Staphylococcal superantigens cause lethal pulmonary disease in rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Vaccine protection against Staphylococcus aureus pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Superantigens and their potential role in human disease

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRMICRO3308

31 March 2020

12 December 2020

Toxic shock syndrome and bacterial superantigens: an update

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Biogenic Amine Involvement in Pyrogenicity and Enhancement of Lethal Endotoxin Shock by Group A Streptococcal Pyrogenic Exotoxin

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRMICRO3308

31 March 2020

12 December 2020

Extreme pyrexia and rapid death due to Staphylococcus aureus infection: analysis of 2 cases

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

TLR SIGNALING PATHWAY IN PATIENTS WITH SEPSIS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Biological Activities of Lipid A Complexed with Bovine-Serum Albumin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Staphylococcus aureus exotoxins are present in vivo in tampons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Glycerol monolaurate does not alter rhesus macaque (Macaca mulatta) vaginal lactobacilli and is safe for chronic use

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Vaginal colonization with Escherichia coli in healthy women. Determination of relative risks by quantitative culture and multivariate statistical analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Evidence for the involvement of endotoxin in toxic shock syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Biphasic assembly of the murine intestinal microbiota during early development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Vaccination against Staphylococcus aureus pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-ResistantStaphylococcus aureusBacteremia in an Experimental Model of Infective Endocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Immunotherapeutic strategies to combat staphylococcal infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3308

Natural history of infection with Pasteurella multocida in rabbits

31 March 2020

1 reference

12 December 2020

Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock

1 reference

12 December 2020

Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats

1 reference

12 December 2020

Exotoxins of Staphylococcus aureus

1 reference

12 December 2020

Transgenic rabbit models for studying human cardiovascular diseases

1 reference

12 December 2020

Staphylococcal scarlet fever: role of pyrogenic exotoxins

1 reference

12 December 2020

TLR4 as the mammalian endotoxin sensor

1 reference

12 December 2020

Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins

1 reference

12 December 2020

A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge

1 reference

12 December 2020

Inhibition of ribonucleic acid synthesis by group A streptococcal pyrogenic exotoxin.

1 reference

12 December 2020

Alpha-toxin of Staphylococcus aureus

1 reference

12 December 2020

Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis

1 reference

12 December 2020

Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus

1 reference

12 December 2020

Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein.

1 reference

12 December 2020

Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis

1 reference

12 December 2020

Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells

1 reference

12 December 2020

Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C

1 reference

12 December 2020

Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model

1 reference

12 December 2020

Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRMICRO3308

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24998740%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference